Cue Biopharma, Inc. Quarterly Operating Leases, Future Minimum Payments, Due in Two Years in USD from Q1 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Summary
Cue Biopharma, Inc. quarterly Operating Leases, Future Minimum Payments, Due in Two Years history and growth rate from Q1 2018 to Q3 2022.
  • Cue Biopharma, Inc. Operating Leases, Future Minimum Payments, Due in Two Years for the quarter ending September 30, 2022 was $3.37M, a 39.8% increase year-over-year.
Operating Leases, Future Minimum Payments, Due in Two Years, Quarterly (USD)
Operating Leases, Future Minimum Payments, Due in Two Years, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $3.37M +$958K +39.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.26M +$847K +35.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.53M +$3.13M +130% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.75M +$2.35M +97.5% Dec 31, 2021 10-K 2022-03-16
Q3 2021 $2.41M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.41M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $2.41M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $2.41M +$1.04M +76.6% Dec 31, 2020 10-K 2021-03-09
Q4 2019 $1.36M -$4.91B Dec 31, 2019 10-K 2020-03-12
Q4 2018 $4.91B* Dec 31, 2018 10-K 2019-03-14
Q3 2018 $4.46M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $3.58M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $3.75M Mar 31, 2018 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.